PETER BUCH, MD, AGAF, FACP

Discover the answers to many common GI dilemmas from expert Peter Buch, MD, FACG, AGAF, FACP. Acquire new clinical tools and insights to help you address the unique GI challenges with your geriatric patients.

Read more...

Peter Buch, MD, AGAF, FACP, is a clinical gastroenterologist with over 30 years of specialty experience to draw from.  His current practice is in Manchester, Connecticut where he has assembled a team that treats all GI conditions.  "We pride ourselves in giving each patient the time and care they need" says Dr Buch.  This has resulted in outstanding patient evaluations and much better outcomes.



Dr. Buch has a passion for teaching.  His style is case based, practical, very interactive and evidence supported.  Dr. Buch's expertise has been shared with experienced clinicians and advanced level students.  He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.

 





Speaker Disclosures:



Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives a speaking honorarium and recording royalties from PESI, Inc.. He has no relevant financial relationships with ineligible organizations.



Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the  American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.

 



Content Disclosure:



Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome; and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.